ACADIA PHARMACEUTICALS INC — Director's Dealing 2015

Aug 21, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2015-08-19

Reporting Person: Iversen Leslie L (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-19	Common Stock	M	8500	$11	Acquired	36127	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-19	Stock option (right to buy)	$11	M	8500	Disposed	2015-09-08	Common Stock (8500)	Direct

Footnotes

F1: 25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the date of grant of September 9, 2005.